New device could protect tiny babies from dangerous low blood sugar

NCT ID NCT01942239

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested whether a real-time continuous glucose monitor could help detect and manage low blood sugar (hypoglycemia) in very low birth weight newborns. 48 infants were randomly assigned to either the continuous monitor or standard finger-stick testing for their first three days of life. The goal was to see if the monitor reduced the number and duration of hypoglycemia episodes, which can harm brain development.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
real-time continuous glucose monitoring device
What this could lead to
If successful, this could lead to better management of low blood sugar in fragile newborns, potentially reducing brain damage risk.
What could go wrong
This is a small, single-center study with only 48 infants. Results may not apply to all hospitals or babies, and the device may not catch all low sugar events.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPOGLYCEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UH Tours Clocheville hospital

    Tours, 37000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.